Company / Net Debt per Share
Bio-Rad Laboratories Net Debt per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$23.05
FY2025
5-year range
$23.05 / $26.69
FY2022-FY2025
Trend
-3.6%
vs FY2024
Sector context
#22 of 98
Health Care
What the data says
Bio-Rad Laboratories's net debt per share of $23.05 is higher than 78% of companies in the Health Care sector (FY2025). Improved from $26.69 to $23.05 over the past 2 years.
Based on SEC 10-K filings.
23.05 in FY2025 with a 3-year CAGR of -3.1%. Top quartile in the Health Care sector.
Improved from $26.69 to $23.05 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -3.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 98This company $23.05 Sector average $7.39
▼
+211.8% above sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 3.6% year-over-year.
- Ranks #22 out of 98 companies in the Health Care sector.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.05 | -3.6% |
| FY2024 | $23.91 | -10.4% |
| FY2023 | $26.69 | +5.4% |
| FY2022 | $25.31 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026